Two-week Intensive Outpatient Trauma Treatment.

The objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. The efficacy of treatment will be investigated using validated self-report forms, which measure PTSD symptoms (PCL-5 and ITQ) and quality of life/function (WHO-5, and WSAS). The measurements will be done before the treatment and one and twelve weeks after treatment.In-depth interviews will also be conducted with up to 30 patients to investigate the outcome and any need for adjustments with focus on patients with minority backgrounds, men and patients with limited benefit. The study uses a mixed methods design, where quantitative measures and information from qualitative interviews are combined to map participants' experience, benefits and feasibility.

Study Overview

• Status: Recruiting
• Conditions: Posttraumatic Stress Disorder (PTSD)
• Intervention / Treatment: Other: Prolonged exposure and EMDR

Detailed Description

The objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. The efficacy of treatment will be investigated using validated self-report forms, which measure PTSD symptoms (PCL-5 and ITQ) and quality of life/function (WHO-5, and WSAS). The measurements will be done before the treatment and one and twelve weeks after treatment. In-depth interviews will also be conducted with up to 30 patients to investigate the outcome and any need for adjustments with focus on patients with minority backgrounds, males and patients with limited benefit. The study uses a mixed methods design, where quantitative measures and information from qualitative interviews are combined to map participants' experience, benefits and feasibility.

• Study Type: Interventional
• Enrollment (Estimated): 42
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Julie H Evensen, MD PhD; Phone Number: 004799339292; Email: uxevej@ous-hf.no
• Study Contact Backup: Name: Veronica Vaage-Kowalzik, MD; Email: UXVAAG@ous-hf.no

Study Locations

• Norway
  • Oslo, Norway
    • Recruiting
    • Oslo University Hospital
    • Contact: Julie Evensen, MD PhD; Phone Number: 004799339292; Email: uxevej@ous-hf.no

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• PTSD
• 18-65 years
• Able to give written informed consent.

Exclusion Criteria:

• Active substance abuse
• psychotic or bipolar disorder
• organic brain disorder
• IQ< 70
• Currently in a life-threating situation.
• Serious suicide risk.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intensive trauma treatment	Other: Prolonged exposure and EMDR; Two-week intensive traume treatment; Other Names: EMDR; prolonged exposure

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Trauma symptom score as measured by International Trauma Questionnaire (ITQ)	ITQ: Higher score equals higher symptom load	12 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Function as measured by Work and social adjustment scale (WSAS)	Higher scores equals poorer function	12 weeeks

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of life as measured by WHO-5, PTSD symptom load as measured by PCL-5	Higher scores on WHO-5 equals better QoL, Higher scores on PCL-5 equal more PTSD symptoms	12 weeks

Collaborators and Investigators

• Sponsor: Oslo University Hospital
• Investigators: Principal Investigator: Julie H Evensen, MD PhD, Oslo University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): January 26, 2026
• Primary Completion (Estimated): December 31, 2027
• Study Completion (Estimated): December 31, 2027

Study Registration Dates

• First Submitted: February 20, 2026
• First Submitted That Met QC Criteria: April 27, 2026
• First Posted (Actual): May 4, 2026

Study Record Updates

• Last Update Posted (Actual): May 4, 2026
• Last Update Submitted That Met QC Criteria: April 27, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Keywords: qualitative study; EMDR; Prolonged exposure; Intensive trauma treatment
• Additional Relevant MeSH Terms: Trauma and Stressor Related Disorders; Mental Disorders; Stress Disorders, Traumatic; Stress Disorders, Post-Traumatic; Behavior Therapy; Psychotherapy; Behavioral Disciplines and Activities; Desensitization, Psychologic; Eye Movement Desensitization Reprocessing
• Other Study ID Numbers: 260225

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No